BioCam

A little late, but today we are back with a few impressions from the first veterinary conference where BioCam was represented by the Technomed team, our official PetCam by BioCam distributor in Poland.

The XXIV Stowarzyszenie Śląska Poliklinika Weterynaryjna POLIWET Conference in Wisła brought together around 250 veterinary professionals for three days of practical sessions, focused discussions, and shared experience around emergency cases and everyday clinical challenges.

At the Technomed stand, visitors could learn more about BioCam’s veterinary technology and see the full setup up close, including the data receiver, diagnostic pet's vests and the endoscopic capsule. It was a good opportunity to talk through how PetCam fits into real veterinary workflows and why it matters for GI diagnostics.

With the commercialization process underway, we can now meet more veterinary professionals at industry events, answer practical questions directly, and keep building awareness around capsule endoscopy in a way that is clear and grounded.

BioCam's logo is now officially EU trademark registered (No 019029744, published March 2, 2026 in EUIPO Bulletin 2026/040). This gives us strong IP footing as the company grows. 🌍

Over the years, we've learned a key lesson about making real progress. Instead of throwing all our energy at one goal, we work on several fronts at once: R&D, partnerships, regulatory steps, clinical prep, veterinary comercialization. Sure, it doesn't let us sprint ahead in a straight line. But each piece strengthens the whole. It builds a solid foundation, creates a network of reliable partners around us, and lets us scale sustainably right from the start.​

BioCam staying focused and balanced. 2026 is about turning that into growth.

Preparations ramp up for clinical trials. BioCam gears up for multi-center studies on 128 patients this year, building robust evidence for capsule endoscopy. 🥼 🩺

Recent commercial partnerships power this: www.devgomed.com handling medical writing and quality management, www.cleandatalabs.com on biostatistics, and GENELYTICA as CRO for trial ex*****on.

Vet commercialization rolls on. Human validation next, with NBI imaging and AI analysis ready from pilots to prove real impact. Focus stays sharp: real-world diagnostics that deliver.

Milestones in motion.

During last tests, we've put Narrow Band Imaging (NBI) to the examination in PetCam's first veterinary patients, and vets report far sharper diagnostic details emerging in green light. 🟢

​

Surface changes pop. Gastrointestinal pathologies stand out like never before. No competitor offers NBI in capsule endoscopy; BioCam is breaking new ground with dual-mode imaging (standard + NBI).

​

Independent vets confirm it: more precise pathology detection in real cases, powering evidence-driven decisions.

​

Our cloud platform shines here: side-by-side frames let clinicians compare modes effortlessly, from upload to report.

​

More to come — revolutionizing vet GI screening.